Sopharma stock holds at EUR 4.26 as dated market data show limited evidence

Sopharma stock (ISIN BG11SOSOBT18) was listed at EUR 4.26 on September 22, 2026, in the available quoted market data. The figure provides a dated reference point for the Bulgarian pharmaceutical company, while the search record does not establish a same-day percentage change or a completed-session closing status.

EUR 4.26 is the dated reference

The quoted EUR 4.26 value is associated with Sopharma on September 22, 2026, but the available page does not provide a reliable primary-exchange timestamp, prior close, trading volume or market capitalization. Those figures are therefore not included as current market data.

The quotation also does not establish a valid 52-week high or low for the same reference period. A price comparison with a range would require consistent values from one dated market snapshot.

Reported figures need a dated period

Sopharma's operating figures are relevant only when tied to a clearly identified quarter, half-year or fiscal year. The available results do not provide a sufficiently substantiated current reporting-period figure for revenue, earnings, margin or guidance that can be attributed to the company in this article.

That distinction matters because a recently published page can repeat older financial data. For a same-day stock article, the reporting period itself must be visible, not merely the publication date.

Market reference remains EUR 4.26

For the dated market reference, Sopharma stock stands at EUR 4.26 on September 22, 2026. The value is presented without an inferred daily direction, valuation claim or investment recommendation.

More news and analyses on Sopharma stock